Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells

Experimental Hematology

Volumn 38, Issue 5, 2010, Pages 373-383

  de Totero, Daniela ^a   Capaia, Matteo ^a   Fabbi, Marina ^a   Croce, Michela ^a   Meazza, Raffaella ^b   Cutrona, Giovanna ^a   Zupo, Simona ^a   Loiacono, Fabrizio ^a   Truini, Mauro ^a   Ferrarini, Manlio ^a,c   Ferrini, Silvano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; JANUS KINASE; JANUS KINASE 3; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

APOPTOSIS; ARTICLE; CELL GROWTH; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYMPHOMA CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-21 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; JANUS KINASE 3; JANUS KINASES; LYMPHOMA, FOLLICULAR; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSLOCATION, GENETIC;

EID: 77951451872     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.02.008     Document Type: Article

References (35)

1. Spolski R., Leonard W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Ann Rev Immunol 2008, 26:57-79. [review].
2. Asao H., Okuyama C., Kumaki S., et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL21 receptor complex. J Immunol 2001, 167:1-5.
3. Zeng R., Spolski R., Casas E., Zhu W., Levy D.E., Leonard W.J. The molecular basis of IL21-mediated proliferation. Blood 2007, 109:4135-4142.
4. de Totero D., Meazza R., Capaia M., et al. The opposite effects of IL-15 and IL21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 2008, 111:517-524.
5. Ozaki K., Spolski R., Feng C.G., et al. A critical role for IL21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
6. Konforte D., Simard N., Paige C.J. IL21: an executor of B cell fate. J Immunol 2009, 182:1781-1787.
7. Di Carlo E., de Totero D., Piazza T., Fabbi M., Ferrini S. Role of IL21 in immune-regulation and tumor immunotherapy. Cancer Immunol Immunother 2007, 56:1323-1334.
8. Roda J.M., Parihar R., Lehman A., Mani A., Tridandapani S., Carson W.E. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol 2006, 177:120-129.
9. Ueda M., Imada K., Imura A., Koga H., Hishizawa M., Uchiyama T. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol 2005, 128:169-176.
10. Brenne A.T., Baade Ro T., Waage A., Sundan A., Borset M., Hjorth-Hansen H. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood 2002, 99:3756-3762.
11. Scheeren F.A., Diehl S.A., Smit L.A., et al. IL21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 2008, 111:4706-4715.
12. de Totero D., Meazza R., Zupo S., et al. Interleukin-21 receptor (IL21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 2006, 107:3708-3715.
13. Jahrsdorfer B., Blackwell S.E., Wooldridge J.E., et al. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood 2006, 108:2712-2719.
14. Gowda A., Roda J., Hussain S.R., et al. IL21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood 2008, 111:4723-4730.
15. Akamatsu N., Yamada Y., Hasegawa H., et al. High IL21 receptor expression and apoptosis induction by IL21 in follicular lymphoma. Cancer Lett 2007, 256:196-206.
16. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392.
17. Harris N., Jaffe E., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematomoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999, 17:3835-3849.
18. Meazza R., Basso S., Gaggero A., et al. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma. Int J Cancer 1998, 78:189-195.
19. Huber M., Brüstle A., Reinhard K., et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 2008, 105:20846-20851.
20. Rückert R., Bulfone-Paus S., Brandt K. Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin Exp Immunol 2008, 151:487-495.
21. Strengell M., Lehtonen A., Matikainen S., Julkunen I. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J Leukoc Biol 2006, 79:1279-1285.
22. Buske C., Twiling A., Gogowski G., et al. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand. Leukemia 1997, 11:1862-1867.
23. Calvo K.R., Dabir B., Kovach A., et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 2008, 112:3818-3822.
24. Ratthé C., Girard D. Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced SOCS3 protein expression. Br J Haematol 2008, 140:59-70.
25. Canfield S., Lee Y., Schroder A., Rothman P. Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J Immunol 2005, 174:2494-2498.
26. Lwin T., Hazlehurst L.A., Li Z., et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia 2007, 21:1521-1531.
27. Russell S.M., Tayebi N., Nakajima H., et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995, 270:797-800.
28. Konforte D., Paige C.J. Identification of cellular intermediates and molecular pathways induced by IL21 in human B cells. J Immunol 2006, 177:8381-8392.
29. Sarosiek K.A., Malumbres R., Nechushtan H., Gentles A.J., Avisar E., Lossos I.S. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood 2010, 115:570-580.
30. Ghia P., Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res 2000, 79:157-173.
31. Küppers R. Prognosis in follicular lymphoma-it's in the microenvironment. N Engl J Med 2004, 351:2152-2153.
32. Kluin-Nelemans H.C., Limpens J., Meerabux J., et al. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21). Leukemia 1991, 5:221-224.
33. Krishnadasan R., Bifulco C., Kim J., Rodov S., Zieske A.W., Vanasse G.J. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma. Brit J Haematol 2006, 135:72-75.
34. Robetorye R.S., Bohling S.D., Morgan J.W., Fillmore G.C., Lim M.S., Elenitoba-Johnson K.S. Microarray analysis of B-cell lymphoma cell lines with the t(14;18). J Mol Diagn 2002, 4:123-136.
35. Spolski R., Leonard W.J. IL-21 and follicular helper cells. Int Immunol 2010, 22:7-12.